These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22946512)

  • 1. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.
    Martino M; Bottini A; Rosti G; Generali D; Secondino S; Barni S; Maisano R; Lanza F; Castagna L; Pedrazzoli P
    Expert Opin Biol Ther; 2012 Nov; 12(11):1505-15. PubMed ID: 22946512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.
    Pedrazzoli P; Martino M; Delfanti S; Generali D; Rosti G; Bregni M; Lanza F;
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):70-5. PubMed ID: 26063892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
    Pedrazzoli P; Martinelli G; Gianni AM; Da Prada GA; Ballestrero A; Rosti G; Frassineti GL; Aieta M; Secondino S; Cinieri S; Fedele R; Bengala C; Bregni M; Grasso D; De Giorgi U; Lanza F; Castagna L; Bruno B; Martino M;
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):501-6. PubMed ID: 24374214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.
    Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A
    Eur J Cancer; 2016 Apr; 57():118-26. PubMed ID: 26918737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
    Berry DA; Ueno NT; Johnson MM; Lei X; Caputo J; Rodenhuis S; Peters WP; Leonard RC; Barlow WE; Tallman MS; Bergh J; Nitz UA; Gianni AM; Basser RL; Zander AR; Coombes RC; Roché H; Tokuda Y; de Vries EG; Hortobagyi GN; Crown JP; Pedrazzoli P; Bregni M; Demirer T
    J Clin Oncol; 2011 Aug; 29(24):3214-23. PubMed ID: 21768471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
    Hamilton BK; Rybicki L; Abounader D; Andresen S; Kalaycio M; Sobecks R; Pohlman B; Hanna R; Dean R; Liu H; Hill B; Bolwell B; Copelan E
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):115-24. PubMed ID: 26183670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
    Bashey A; Corringham S; Garrett J; Lane TA; Gilpin EA; Corringham RE; Law P; Ho AD
    Bone Marrow Transplant; 2000 Mar; 25(5):519-24. PubMed ID: 10713629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].
    Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A
    Bull Cancer; 2017 Apr; 104(4):332-343. PubMed ID: 28214007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer.
    McCauley DL
    Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancer.
    Pedrazzoli P; Tarenzi E; Tullio C; Colosini G; Siena S
    J Chemother; 2004 Nov; 16 Suppl 4():108-11. PubMed ID: 15688624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
    Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
    Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
    Peters WP; Dansey RD; Klein JL; Baynes RD
    Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
    Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
    Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
    Cagnoni PJ; Nieto Y; Shpall EJ; Bearman SI; Barón AE; Ross M; Matthes S; Dunbar SE; Jones RB
    J Clin Oncol; 1998 May; 16(5):1661-8. PubMed ID: 9586876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
    Vredenburgh JJ; Coniglio D; Broadwater G; Jones RB; Ross M; Shpall EJ; Hussein A; Rizzieri D; Marks LB; Gilbert C; Affronti ML; Moore S; McDonald C; Petros WP; Peters WP
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):195-203. PubMed ID: 16443517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
    Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
    Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma].
    Kier P; Ruckser R; Buxhofer V; Habertheuer KH; Zelenka P; Tatzreiter G; Hübl G; Kittl E; Hauser A; Sebesta C; Hinterberger W
    Acta Med Austriaca Suppl; 2000; 52():33-6. PubMed ID: 11261276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
    Pedrazzoli P; Ferrante P; Kulekci A; Schiavo R; De Giorgi U; Carminati O; Marangolo M; Demirer T; Siena S; Rosti G;
    Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.